BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 19149562)

  • 1. Recent progress in the discovery of macrocyclic compounds as potential anti-infective therapeutics.
    Obrecht D; Robinson JA; Bernardini F; Bisang C; DeMarco SJ; Moehle K; Gombert FO
    Curr Med Chem; 2009; 16(1):42-65. PubMed ID: 19149562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Update on the Anti-infective Potential of β-carboline Analogs.
    Faheem ; Kumar BK; Sekhar KVGC; Kunjiappan S; Jamalis J; Balaña-Fouce R; Sankaranarayanan M
    Mini Rev Med Chem; 2021; 21(4):398-425. PubMed ID: 33001013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Trends in Macrocyclic Drug Discovery and beyond-Ro5.
    Alihodžić S; Bukvić M; Elenkov IJ; Hutinec A; Koštrun S; Pešić D; Saxty G; Tomašković L; Žiher D
    Prog Med Chem; 2018; 57(1):113-233. PubMed ID: 29680148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient synthesis of novel 1,2,4-triazole fused acyclic and 21-28 membered macrocyclic and/or lariat macrocyclic oxaazathia crown compounds with potential antimicrobial activity.
    Khalil NS
    Eur J Med Chem; 2010 Nov; 45(11):5265-77. PubMed ID: 20875694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel antimicrobial compounds identified using synthetic combinatorial library technology.
    Blondelle SE; Houghten RA
    Trends Biotechnol; 1996 Feb; 14(2):60-5. PubMed ID: 8746118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of bis-imidazolidineiminothiones: a comparative study.
    El-Sharief MA; Moussa Z; El-Sharief AM
    Arch Pharm (Weinheim); 2013 Jul; 346(7):542-55. PubMed ID: 23836516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marine peptides and their anti-infective activities.
    Kang HK; Seo CH; Park Y
    Mar Drugs; 2015 Jan; 13(1):618-54. PubMed ID: 25603351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-hairpin peptidomimetics: design, structures and biological activities.
    Robinson JA
    Acc Chem Res; 2008 Oct; 41(10):1278-88. PubMed ID: 18412373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Synthesis of a Spirocyclic Macrocyclic Protease Inhibitor for the Treatment of Hepatitis C.
    Chung CK; Cleator E; Dumas AM; Hicks JD; Humphrey GR; Maligres PE; Nolting AF; Rivera N; Ruck RT; Shevlin M
    Org Lett; 2016 Mar; 18(6):1394-7. PubMed ID: 26950496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in macrocyclic peptide-based antibiotics.
    Luther A; Bisang C; Obrecht D
    Bioorg Med Chem; 2018 Jun; 26(10):2850-2858. PubMed ID: 28886999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel isoquinoline derivatives as antimicrobial agents.
    Galán A; Moreno L; Párraga J; Serrano Á; Sanz MJ; Cortes D; Cabedo N
    Bioorg Med Chem; 2013 Jun; 21(11):3221-30. PubMed ID: 23601815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and pharmacological studies of some 2-t-amino and 2,3-di-t-amino substituted 1,4-naphthoquinones and related compounds.
    Tandon VK; Singh RV; Rai S; Chhor RB; Khan ZK
    Boll Chim Farm; 2002; 141(4):304-10. PubMed ID: 12426819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of florylpicoxamid, a mimic of a macrocyclic natural product.
    Meyer KG; Bravo-Altamirano K; Herrick J; Loy BA; Yao C; Nugent B; Buchan Z; Daeuble JF; Heemstra R; Jones DM; Wilmot J; Lu Y; DeKorver K; DeLorbe J; Rigoli J
    Bioorg Med Chem; 2021 Nov; 50():116455. PubMed ID: 34757295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modular Synthesis of Diverse Natural Product-Like Macrocycles: Discovery of Hits with Antimycobacterial Activity.
    Dow M; Marchetti F; Abrahams KA; Vaz L; Besra GS; Warriner S; Nelson A
    Chemistry; 2017 May; 23(30):7207-7211. PubMed ID: 28374952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrocyclic polyesters. I. A novel class of 1,3-butandiol derivatives as potential antimicrobial agents.
    Fadda AM; Maccioni AM; Maccioni E; Podda G
    Farmaco; 1992 Jan; 47(1):99-110. PubMed ID: 1616581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Template synthesis, spectroscopic studies, antimicrobial, nematicidal and pesticidal activities of chromium(III) macrocyclic complexes.
    Masih I; Fahmi N; Rajkumar
    J Enzyme Inhib Med Chem; 2013 Feb; 28(1):33-40. PubMed ID: 21999479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicochemical and biological characterization of novel macrocycles derived from o-phthalaldehyde.
    Reddy PM; Ho YP; Shanker K; Rohini R; Ravinder V
    Eur J Med Chem; 2009 Jun; 44(6):2621-5. PubMed ID: 18996622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the anti-infective properties of prodiginines.
    You Z; Zhang S; Liu X; Zhang J; Wang Y; Peng Y; Wu W
    Appl Microbiol Biotechnol; 2019 Apr; 103(7):2873-2887. PubMed ID: 30761415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrocyclic peptidomimetics with antimicrobial activity: synthesis, bioassay, and molecular modeling studies.
    Ibrahim MA; Panda SS; Oliferenko AA; Oliferenko PV; Girgis AS; Elagawany M; Küçükbay FZ; Panda CS; Pillai GG; Samir A; Tämm K; Hall CD; Katritzky AR
    Org Biomol Chem; 2015 Sep; 13(36):9492-503. PubMed ID: 26256838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.